United States · FDA National Drug Code directory
Levothyroxine Sodium
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 42292-038_3a991bf1-d9aa-b137-e063-6294a90af2cf
- Product NDC
- 42292-038
- Form
- TABLET
- Composition / generic term
- levothyroxine sodium
- Labeler
- Mylan Institutional Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20170118
- Source listing expiry
- 20261231
Source-listed ingredients
- LEVOTHYROXINE SODIUM — 88 ug/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 BLISTER PACK in 1 CARTON (42292-038-20) / 1 TABLET in 1 BLISTER PACK (42292-038-01) · 42292-038-20
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →